Global Health Limited has informed the Exchange about Resignation of Director/KMP/SMP
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Midcap 150 and 2.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Global Health Limited (Medanta) reported strong FY26 results with consolidated revenue of Rs 44,103 million (up 19.4% YoY) and PAT of Rs 5,541 million (up 15.1% YoY). The Board approved an unmodified audit report and recommended a final dividend of Rs 0.50 per share (25% on face value Rs 2). Two new SMPs were appointed: Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel, both effective May 14, 2026. Ms. Richa Singh resigned as SMP effective May 20, 2026. The company also announced plans to build a 400-bed hospital in Varanasi via a built-to-suit lease and signed a Business Transfer Agreement for a 79-bed oncology hospital in Indore.
Positive set of results with revenue and profit growth; clean audit provides confidence. SMP resignation is minor given new appointments being made. Expansion plans signal growth focus.